Interleukin-2 and PD-1 synergistically modify T cell exhaustion programs

Affiliations

¹ Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: xcli@houstonmethodist.org.

Free article

Comment

Paolo Cravedi et al. Am J Transplant. 2023 Feb.

Free article

. 2023 Feb;23(2):161-162.

doi: 10.1016/j.ajt.2023.01.002. Epub 2023 Jan 14.

¹ Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Immunobiology and Transplant Science Center and Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: xcli@houstonmethodist.org.

No abstract available

Comment on

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8⁺ T cells.
Codarri Deak L, Nicolini V, Hashimoto M, Karagianni M, Schwalie PC, Lauener L, Varypataki EM, Richard M, Bommer E, Sam J, Joller S, Perro M, Cremasco F, Kunz L, Yanguez E, Hüsser T, Schlenker R, Mariani M, Tosevski V, Herter S, Bacac M, Waldhauer I, Colombetti S, Gueripel X, Wullschleger S, Tichet M, Hanahan D, Kissick HT, Leclair S, Freimoser-Grundschober A, Seeber S, Teichgräber V, Ahmed R, Klein C, Umaña P. Codarri Deak L, et al. Nature. 2022 Oct;610(7930):161-172. doi: 10.1038/s41586-022-05192-0. Epub 2022 Sep 28. Nature. 2022. PMID: 36171284 Free PMC article.
PD-1 combination therapy with IL-2 modifies CD8⁺ T cell exhaustion program.
Hashimoto M, Araki K, Cardenas MA, Li P, Jadhav RR, Kissick HT, Hudson WH, McGuire DJ, Obeng RC, Wieland A, Lee J, McManus DT, Ross JL, Im SJ, Lee J, Lin JX, Hu B, West EE, Scharer CD, Freeman GJ, Sharpe AH, Ramalingam SS, Pellerin A, Teichgräber V, Greenleaf WJ, Klein C, Goronzy JJ, Umaña P, Leonard WJ, Smith KA, Ahmed R. Hashimoto M, et al. Nature. 2022 Oct;610(7930):173-181. doi: 10.1038/s41586-022-05257-0. Epub 2022 Sep 28. Nature. 2022. PMID: 36171288 Free PMC article.